Italy's Alfasigma To Acquire Intercept Pharmaceuticals For $19.00 Per Share In Cash
Portfolio Pulse from Benzinga Newsdesk
Italy's Alfasigma has agreed to acquire Intercept Pharmaceuticals for $19.00 per share in cash. The deal is expected to close in the first quarter of 2023.
September 26, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Intercept Pharmaceuticals is being acquired by Alfasigma for $19.00 per share in cash. This could potentially lead to a short-term increase in the stock price.
The acquisition news typically leads to a short-term increase in the stock price of the company being acquired. In this case, Intercept Pharmaceuticals' shareholders will receive $19.00 per share in cash, which could potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100